Cargando…

A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease

To analyze outcomes following major lower extremity amputations (mLEAs) for peripheral arterial obstructive disease, gangrene, infected non-healing wound and to create a risk prediction scoring system for 30-day mortality. In this single-center, retrospective, observational cohort study. All patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchin, Marco, Palermo, Vincenzo, Iannuzzi, Carlo, Rivolta, Nicola, Mozzetta, Gaddiel, Tozzi, Matteo, Bush, Ruth L., Piffaretti, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500910/
https://www.ncbi.nlm.nih.gov/pubmed/34120323
http://dx.doi.org/10.1007/s13304-021-01085-5
_version_ 1784580546271117312
author Franchin, Marco
Palermo, Vincenzo
Iannuzzi, Carlo
Rivolta, Nicola
Mozzetta, Gaddiel
Tozzi, Matteo
Bush, Ruth L.
Piffaretti, Gabriele
author_facet Franchin, Marco
Palermo, Vincenzo
Iannuzzi, Carlo
Rivolta, Nicola
Mozzetta, Gaddiel
Tozzi, Matteo
Bush, Ruth L.
Piffaretti, Gabriele
author_sort Franchin, Marco
collection PubMed
description To analyze outcomes following major lower extremity amputations (mLEAs) for peripheral arterial obstructive disease, gangrene, infected non-healing wound and to create a risk prediction scoring system for 30-day mortality. In this single-center, retrospective, observational cohort study. All patients treated with above-the-knee amputation (AKA) or below-the-knee amputation (BKA) between January 1st, 2010 and June 30th, 2018 were identified. The primary outcome of interest was early (≤ 30 days) mortality. Secondary outcomes were postoperative complications and freedom from amputation stump revision/failure. We identified 310 (77.7%) mLEAs performed on 286 patients. There were 188 (65.7%) men and 98 (34.3%) women with a median age of 79 years (IQR, 69–83 years). We performed 257 (82.9%) AKA and 53 (17.1%) BKA. There were 49 (15.8%) early deaths, which did not differ among the age quartiles of this cohort (15.4% vs. 14.3% vs. 15.4% vs. 19.5%, P = 0.826). Binary logistic regression analysis identified age > 80 years (OR 2.24, 95% CI 1.17–4.31; P = 0.015), chronic obstructive pulmonary disease (OR 2.12, 95% CI 1.11–4.06; P = 0.023), and hemodialysis (OR 2.52, 95% CI 1.15–5.52; P = 0.021) to be associated with early mortality. The final score (range 0–10) identified two subgroups with different mortality at 30 days: lower-risk (score < 4, 10.8%), and higher-risk (score ≥ 4: 28.7%; OR 3.2, 95% CI 1.63–6.32; P < 0.001). In our experience, mLEAs still have a 14% mortality rate over the years. Our lower-risk group (score < 4) is characterized by a lower rate of perioperative death and longer survival. GRAPHIC ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8500910
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85009102021-10-22 A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease Franchin, Marco Palermo, Vincenzo Iannuzzi, Carlo Rivolta, Nicola Mozzetta, Gaddiel Tozzi, Matteo Bush, Ruth L. Piffaretti, Gabriele Updates Surg Original Article To analyze outcomes following major lower extremity amputations (mLEAs) for peripheral arterial obstructive disease, gangrene, infected non-healing wound and to create a risk prediction scoring system for 30-day mortality. In this single-center, retrospective, observational cohort study. All patients treated with above-the-knee amputation (AKA) or below-the-knee amputation (BKA) between January 1st, 2010 and June 30th, 2018 were identified. The primary outcome of interest was early (≤ 30 days) mortality. Secondary outcomes were postoperative complications and freedom from amputation stump revision/failure. We identified 310 (77.7%) mLEAs performed on 286 patients. There were 188 (65.7%) men and 98 (34.3%) women with a median age of 79 years (IQR, 69–83 years). We performed 257 (82.9%) AKA and 53 (17.1%) BKA. There were 49 (15.8%) early deaths, which did not differ among the age quartiles of this cohort (15.4% vs. 14.3% vs. 15.4% vs. 19.5%, P = 0.826). Binary logistic regression analysis identified age > 80 years (OR 2.24, 95% CI 1.17–4.31; P = 0.015), chronic obstructive pulmonary disease (OR 2.12, 95% CI 1.11–4.06; P = 0.023), and hemodialysis (OR 2.52, 95% CI 1.15–5.52; P = 0.021) to be associated with early mortality. The final score (range 0–10) identified two subgroups with different mortality at 30 days: lower-risk (score < 4, 10.8%), and higher-risk (score ≥ 4: 28.7%; OR 3.2, 95% CI 1.63–6.32; P < 0.001). In our experience, mLEAs still have a 14% mortality rate over the years. Our lower-risk group (score < 4) is characterized by a lower rate of perioperative death and longer survival. GRAPHIC ABSTRACT: [Image: see text] Springer International Publishing 2021-06-13 2021 /pmc/articles/PMC8500910/ /pubmed/34120323 http://dx.doi.org/10.1007/s13304-021-01085-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Franchin, Marco
Palermo, Vincenzo
Iannuzzi, Carlo
Rivolta, Nicola
Mozzetta, Gaddiel
Tozzi, Matteo
Bush, Ruth L.
Piffaretti, Gabriele
A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
title A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
title_full A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
title_fullStr A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
title_full_unstemmed A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
title_short A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
title_sort predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500910/
https://www.ncbi.nlm.nih.gov/pubmed/34120323
http://dx.doi.org/10.1007/s13304-021-01085-5
work_keys_str_mv AT franchinmarco apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT palermovincenzo apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT iannuzzicarlo apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT rivoltanicola apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT mozzettagaddiel apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT tozzimatteo apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT bushruthl apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT piffarettigabriele apredictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT franchinmarco predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT palermovincenzo predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT iannuzzicarlo predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT rivoltanicola predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT mozzettagaddiel predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT tozzimatteo predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT bushruthl predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease
AT piffarettigabriele predictivescorefor30daysurvivalforpatientsundergoingmajorlowerlimbamputationforperipheralarterialobstructivedisease